To the full analysis
Buyback calculator for Divi's Laboratories
Divi's Laboratories stock: key metrics
DIVISLAB.NSDivi's Laboratories had an operating margin of 28.2% and a return on invested capital (ROIC) of 18.2% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2007 | 79.6% | 30.3% | 25.7% |
| 2008 | 188.7% | 93.7% | 3.4% |
| 2009 | 75.6% | 28.6% | 35.3% |
| 2010 | 89.2% | 31.3% | 36.1% |
| 2011 | 88.2% | 34.0% | 32.6% |
| 2012 | 91.3% | 33.8% | 28.6% |
| 2013 | 95.5% | 34.5% | 28.1% |
| 2014 | 98.9% | 36.7% | 30.5% |
| 2015 | 92.6% | 33.4% | 27.3% |
| 2016 | 93.0% | 34.6% | 29.9% |
| 2017 | 94.1% | 33.7% | 26.2% |
| 2018 | 87.4% | 29.6% | 23.0% |
| 2019 | 95.9% | 35.6% | 28.2% |
| 2020 | 89.4% | 31.0% | 26.0% |
| 2021 | 64.5% | 38.1% | 28.9% |
| 2022 | 64.9% | 40.6% | 33.6% |
| 2023 | 58.5% | 26.4% | 23.8% |
| 2024 | 58.1% | 23.5% | 20.5% |
| 2025 | 58.5% | 27.6% | 23.5% |
| 2026 | 43.2% | 28.2% | 24.3% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2007 | 34.7% | 27.7% | 22.0% |
| 2008 | 40.4% | no data | 29.5% |
| 2009 | 33.6% | 26.4% | 26.9% |
| 2010 | 22.4% | 17.5% | 18.3% |
| 2011 | 23.9% | 29.6% | 18.9% |
| 2012 | 25.0% | 34.0% | 19.3% |
| 2013 | 24.1% | 30.2% | 19.2% |
| 2014 | 26.1% | 31.9% | 20.8% |
| 2015 | 24.4% | 31.8% | 19.3% |
| 2016 | 26.3% | 33.9% | 23.0% |
| 2017 | 19.8% | 28.6% | 17.2% |
| 2018 | 14.8% | 20.5% | 12.9% |
| 2019 | 19.4% | 25.7% | 16.8% |
| 2020 | 18.8% | 20.7% | 16.1% |
| 2021 | 21.3% | 28.8% | 18.4% |
| 2022 | 25.2% | 35.4% | 22.1% |
| 2023 | 14.3% | 17.7% | 12.6% |
| 2024 | 11.8% | 14.6% | 10.3% |
| 2025 | 14.6% | 18.3% | 12.9% |
| 2026 | 15.3% | 18.2% | 12.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 10 Apr 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.